WHO halts anti-malarial drug HCQ trials, says it does not reduce COVID-19 mortality rate
The announcement came two days after the United States withdrew emergency use authorisations for both hydroxychloroquine and chloroquine.
The announcement came two days after the United States withdrew emergency use authorisations for both hydroxychloroquine and chloroquine.
